Blue Owl Capital Holdings LP Ikena Oncology, Inc. Transaction History
Blue Owl Capital Holdings LP
- $241 Million
- Q2 2024
A detailed history of Blue Owl Capital Holdings LP transactions in Ikena Oncology, Inc. stock. As of the latest transaction made, Blue Owl Capital Holdings LP holds 4,091,118 shares of IKNA stock, worth $7.08 Million. This represents 2.8% of its overall portfolio holdings.
Number of Shares
4,091,118
Previous 3,891,118
5.14%
Holding current value
$7.08 Million
Previous $5.53 Million
22.17%
% of portfolio
2.8%
Previous 1.46%
Shares
3 transactions
Others Institutions Holding IKNA
# of Institutions
73Shares Held
31.2MCall Options Held
0Put Options Held
0-
Atlas Venture Life Science Advisors, LLC5.02MShares$8.68 Million1.1% of portfolio
-
Bvf Inc San Francisco, CA4.77MShares$8.25 Million0.24% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.54MShares$6.12 Million0.14% of portfolio
-
Omega Fund Management, LLC Boston, MA2.25MShares$3.89 Million4.84% of portfolio
-
Chi Advisors LLC New York, NY2.18MShares$3.77 Million4.65% of portfolio
About Ikena Oncology, Inc.
- Ticker IKNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,257,500
- Market Cap $62.7M
- Description
- Ikena Oncology, Inc., a targeted oncology company, focuses on developing medicines tailored to biomarker-defined patient groups for specific unmet needs. Its lead targeted oncology product candidate is IK-930, an oral small molecule inhibitor of the transcriptional enhanced associate domain, transcription factor in the Hippo signaling pathway. I...